| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/06/2014 | US20140066404 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 03/05/2014 | EP2702057A2 Pharmaceutical compositions containing paclitaxel orotate |
| 03/05/2014 | EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists |
| 03/05/2014 | EP2702053A2 Novel rock inhibitors |
| 03/05/2014 | EP2702052A1 17alpha-hydroxylase/c17,20-lyase inhibitors |
| 03/05/2014 | EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase |
| 03/05/2014 | CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists |
| 03/05/2014 | CN103619833A Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 03/05/2014 | CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor |
| 03/05/2014 | CN103613583A 1, 3-substituent-4-substituted pyrazol acylhydrazone derivative and preparation method and application thereof |
| 03/05/2014 | CN103613582A Rosuvastatin lactone |
| 03/05/2014 | CN103613551A Synthesis method for substituted triazole compound |
| 03/05/2014 | CN103613550A Environment-friendly synthesis method for 4(3H)-quinazolinone |
| 03/05/2014 | CN103613541A Preparation method of tetra-substituted olefin and its pyrazole derivatives |
| 03/05/2014 | CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor |
| 03/05/2014 | CN102498091B Glycine compound |
| 03/05/2014 | CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases |
| 03/05/2014 | CN101588716B Substance capable of inhibiting cytokinin signaling |
| 03/05/2014 | CN101495464B Prokineticin 1 receptor antagonists |
| 03/04/2014 | US8664389 Process for the preparation of lapatinib and it's pharmaceutically acceptable salts |
| 03/04/2014 | US8664217 Benzodiazepine compound and pharmaceutical composition |
| 02/27/2014 | WO2014031732A2 Methods for inhibiting fascin |
| 02/27/2014 | WO2014030831A1 Compound for organic optoelectric device, organic light-emitting diode including same, and display device including organic light-emitting diode |
| 02/27/2014 | WO2014030743A1 Heterocycic compound |
| 02/27/2014 | WO2014030688A1 Chromone derivative having linear side chain |
| 02/27/2014 | WO2014030082A1 Novel method to obtain olmesartan medoxomil with reduced particle size |
| 02/27/2014 | WO2014029831A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029830A1 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals |
| 02/27/2014 | WO2014029042A1 2-substituted-2h-1, 2, 3-triazole derivative and preparation method thereof |
| 02/27/2014 | WO2013190137A3 Novel anti-cancer thiophene compounds |
| 02/27/2014 | US20140058120 Tri-substituted 2-benzhydryl-5-benzylamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| 02/27/2014 | US20140058113 Deprotection method for protected hydroxyl group |
| 02/27/2014 | US20140058100 Tetrahydroisoquinolin-1-one derivative or salt thereof |
| 02/27/2014 | US20140058097 Pharmaceutical composition for treating alzheimer's disease |
| 02/27/2014 | US20140058058 Monomers and polymers for functional polycarbonates and poly(ester-carbonates) and peg-co-polycarbonate hydrogels |
| 02/27/2014 | US20140057927 Inhibitors of beta-secretase |
| 02/27/2014 | US20140057926 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | US20140057925 Amorphous form of vilazodone hydrochloride and process for its preparation |
| 02/27/2014 | US20140057920 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | US20140057919 Fluoro-pyridinone derivatives useful as antibacterial agents |
| 02/27/2014 | US20140057916 Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity |
| 02/27/2014 | US20140057915 Kinase inhibitors |
| 02/27/2014 | US20140057910 Heterocyclic aspartyl protease inhibitors |
| 02/27/2014 | US20140057906 Modulators of atp-binding cassette transporters |
| 02/27/2014 | US20140057900 Pro-Neurogenic Compounds |
| 02/27/2014 | US20140057893 Substituted cycloproply compounds, compositions containing such compounds and methods of treatment |
| 02/27/2014 | US20140057891 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds |
| 02/27/2014 | US20140057890 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2014 | US20140057889 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2014 | US20140057863 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation |
| 02/27/2014 | US20140056880 Triazole compounds as ksp inhibitors |
| 02/26/2014 | EP2700628A1 Deprotection method for protected hydroxyl group |
| 02/26/2014 | EP2699563A1 Novel pesticidal pyrazole compounds |
| 02/26/2014 | EP2699554A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines |
| 02/26/2014 | EP2699553A1 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith |
| 02/26/2014 | CN103608335A Pyrimidine derivatives for the treatment of viral infections |
| 02/26/2014 | CN103608332A Pyridin-2-amides useful as CB2 agonists |
| 02/26/2014 | CN103601722A Novel antineoplastic compounds |
| 02/26/2014 | CN103601721A 3-furylbis(benzodiazepine)-1-one series derivatives, and preparation method and application thereof |
| 02/26/2014 | CN103601718A O-formammidotiazol-benzamide derivatives based on ryanodine receptor, and preparation method and applications thereof |
| 02/26/2014 | CN103601711A Coumarin derivative and preparation method and application thereof |
| 02/26/2014 | CN103601710A Coumarin derivative and preparation method and application thereof |
| 02/26/2014 | CN103601684A 5-arylselenobenzimidazole compound and application thereof |
| 02/26/2014 | CN103601681A 3,5-pyrazoldione derivative containing exocyclic double bond structure unit and preparation method and application thereof |
| 02/26/2014 | CN103601674A Compounds for inhibiting dipeptide kininase, preparation method and applications thereof |
| 02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 02/26/2014 | CN101472888B Optical pure chromocor derivate for treating proliferative lesion and preparation method thereof |
| 02/25/2014 | US8658673 BETA2-adrenoreceptor agonists |
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use |
| 02/25/2014 | CA2637308C Use of 4-imidazole derivatives for cns disorders |
| 02/20/2014 | WO2014028931A2 Compounds and methods for treating mammalian gastrointestinal microbial infections |
| 02/20/2014 | WO2014028803A1 Substituted pyrazoles as n-type calcium channel blockers |
| 02/20/2014 | WO2014028801A1 Cyclopentylpyrazoles as n-type calcium channel blockers |
| 02/20/2014 | WO2014028669A1 Novel compounds for modulation of ror-gamma activity |
| 02/20/2014 | WO2014028473A1 New salts of vilazodone and solid state forms thereof |
| 02/20/2014 | WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | WO2014027822A1 Novel compound and organic electroluminescent device comprising same |
| 02/20/2014 | WO2014027053A1 Benzimidazoles for the treatment of cancer |
| 02/20/2014 | WO2014026882A1 Azaheterocycles as bir2 and/or bir3 inhibitors |
| 02/20/2014 | WO2009021750A3 Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy |
| 02/20/2014 | US20140051727 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof |
| 02/20/2014 | US20140051722 Topical lfa-1 antagonists for use in localized treatment of immune related disorders |
| 02/20/2014 | US20140051713 Novel salts and polymorphic forms of afatinib |
| 02/20/2014 | US20140051709 Compositions and Methods for Treating Myotonic Dystrophy Type 1 |
| 02/20/2014 | US20140051702 Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis |
| 02/20/2014 | US20140051687 Substituted indole compounds having nos inhibitory activity |
| 02/20/2014 | US20140051686 3-Arylamino Pyridine Derivatives |
| 02/20/2014 | US20140051682 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators |
| 02/20/2014 | US20140051681 Mst1 kinase inhibitors and methods of their use |
| 02/20/2014 | US20140051679 Kinase inhibitors and method of treating cancer with same |
| 02/20/2014 | US20140051675 Modulators of cellular adhesion |
| 02/20/2014 | US20140051674 New compounds |
| 02/20/2014 | US20140051673 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same |
| 02/20/2014 | US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions |
| 02/20/2014 | US20140051660 Cyclopentylpyrazoles as n-type calcium channel blockers |
| 02/19/2014 | EP2698368A1 Novel pyrazole derivative |
| 02/19/2014 | EP2698367A1 Benzimidazoles for the treatment of cancer |
| 02/19/2014 | EP2697217A1 Glycoside derivatives and their uses for the treatment of diabetes |
| 02/19/2014 | EP2697216A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |